Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis-Reference-Cited by-同舟云学术

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis

Published:2015-10 Issue:10 Volume:2 Page:e427-e436
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Versluis Jurjen,Hazenberg Carin L E,Passweg Jakob R,van Putten Wim L J,Maertens Johan,Biemond Bart J,Theobald Matthias,Graux Carlos,Kuball Jurgen,Schouten Harry C,Pabst Thomas,Löwenberg Bob,Ossenkoppele Gert,Vellenga Edo,Cornelissen Jan J

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial;Burnett;Br J Haematol,2009

2. High-dose daunorubicin in older patients with acute myeloid leukemia;Lowenberg;N Engl J Med,2009

3. Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial;Goldstone;Blood,2001

4. Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study;Lowenberg;Blood,2010

5. Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia;Burnett;J Clin Oncol,2012

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune Suppression;Transplantation and Cellular Therapy;2024-08

2. Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study;Clinical Cancer Research;2024-03-22

3. CACA guidelines for holistic integrative management of adult acute myeloid leukemia;Holistic Integrative Oncology;2024-03-14

4. Transplantation and Cellular Therapy for Older Adults—The MSK Approach;Current Hematologic Malignancy Reports;2024-02-09

5. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype;Bone Marrow Transplantation;2023-12-13